Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN) Listen to this Section


$3.12
+0.2900 ( +10.25% ) 143.4K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$3.12

Previous close


$2.83

Volume


143.4K

Market cap


$54.59M

Day range


$2.64 - $3.21

52 week range


$1.30 - $3.71

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Oct 18, 2023
4 Insider transactions 1 Sep 06, 2023
10-q Quarterly Reports 57 Aug 07, 2023
8-k 8K-related 14 Aug 07, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.